Bill Text: CA SB1230 | 2015-2016 | Regular Session | Introduced

---

Bill Title: Pharmacies: compounding.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Failed) 2016-11-30 - From committee without further action. [SB1230 Detail]

Download: California-2015-SB1230-Introduced.html

---

BILL NUMBER: SB 1230	INTRODUCED
	BILL TEXT


INTRODUCED BY   Senator Stone

                        FEBRUARY 18, 2016

   An act to add Section 4126.7 to the Business and Professions Code,
relating to pharmacies.


	LEGISLATIVE COUNSEL'S DIGEST


   SB 1230, as introduced, Stone. Pharmacies: compounding.
   Under the Pharmacy Law, a violation of which is a crime, the
California State Board of Pharmacy licenses and regulates the
practice of pharmacy. That law authorizes a pharmacy to furnish
prescription drugs only to certain entities, including specific
health care entities, and individual patients either pursuant to
prescription or as otherwise authorized by law.
   This bill would authorize a pharmacy that provides compounding
services to provide to a clinic commercial products that are unique
or otherwise unavailable to the clinic, if the compounding pharmacy
and the clinic have entered into a professional compounding services
agreement to provide nonpatient-specific compounded medications that
cannot be planned for prospectively. The bill would require the board
to adopt regulations for establishing a professional compounding
services agreement.
   Vote: majority. Appropriation: no. Fiscal committee: yes.
State-mandated local program: no.


THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:

  SECTION 1.  Section 4126.7 is added to the Business and Professions
Code, to read:
   4126.7.  (a) A pharmacy that provides compounding services may
provide to a clinic commercial products that are unique or otherwise
unavailable to the clinic, if the compounding pharmacy and the clinic
have entered into a professional compounding services agreement,
that complies with regulation adopted pursuant to subdivision (b), to
provide nonpatient-specific compounded medications that cannot be
planned for prospectively.
   (b) The board shall adopt regulations for establishing a
professional compounding services agreement.